Immunosuppressive agents in protein-losing nephritis.
D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D006967:Hypersensitivity / Q000145:classification; D007106:Immune Sera; D007166:Immunosuppressive Agents / Q000145:classification / Q000627:therapeutic use*; D007668:Kidney / Q000276:immunology; D009393:Nephritis / Q000209:etiology / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D012713:Serum Sickness / Q000276:immunology
D007106:Immune Sera; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone